J. Scott Garland Insider Trading $PTLA PORTOLA PHARMACEUTICALS INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for J. Scott Garland.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of J. Scott Garland. J. Scott Garland is EVP & Chief Commerical Officer in EXELIXIS, INC. ($EXEL) and President and CEO in PORTOLA PHARMACEUTICALS INC ($PTLA) and SVP & Chief Commercial Officer in Relypsa Inc ($RLYP) and Director in Calithera Biosciences, Inc. ($CALA) and Director in Karyopharm Therapeutics Inc. ($KPTI).

J. Scott Garland in PORTOLA PHARMACEUTICALS INC

Trading Symbol: PTLA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of J. Scott Garland: President and CEO
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jul 02 2020
$PTLA Market Capitalization: $1.55B
$PTLA Previous Close: $28.28

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of J. Scott Garland in PORTOLA PHARMACEUTICALS INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, CALA, EXEL, KPTI, PTLA, RLYP

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 02 2020PTLAPORTOLA PHARMACEUT ...Garland J. ScottPresident and CEOOption ExerciseD0.00153,39900
Jul 02 2020PTLAPORTOLA PHARMACEUT ...Garland J. ScottPresident and CEOOption ExerciseD0.00370,40000
Jul 02 2020PTLAPORTOLA PHARMACEUT ...Garland J. ScottPresident and CEOOption ExerciseD12.79100,0001,279,0000
Jul 02 2020PTLAPORTOLA PHARMACEUT ...Garland J. ScottPresident and CEOOption ExerciseD12.79200,0002,558,0000
Jul 02 2020PTLAPORTOLA PHARMACEUT ...Garland J. ScottPresident and CEOOption ExerciseD0.0050,00000
Jul 02 2020PTLAPORTOLA PHARMACEUT ...Garland J. ScottPresident and CEOOption ExerciseD0.00100,00000
Jul 02 2020PTLAPORTOLA PHARMACEUT ...Garland J. ScottPresident and CEOSellD18.001,17321,11401.2 K to 0 (-100.00 %)
Jul 02 2020PTLAPORTOLA PHARMACEUT ...Garland J. ScottPresident and CEOGrantA8.361,1739,8061,1730 to 1.2 K
Jul 02 2020PTLAPORTOLA PHARMACEUT ...Garland J. ScottPresident and CEOSellD18.0024,529441,522024.5 K to 0 (-100.00 %)
Feb 26 2020PTLAPORTOLA PHARMACEUT ...Garland J. ScottPresident and CEOOption ExerciseA0.00150,0000150,000
Feb 04 2020PTLAPORTOLA PHARMACEUT ...Garland J. ScottPresident and CEOOption ExerciseA12.79200,0002,558,000200,000
Feb 04 2020PTLAPORTOLA PHARMACEUT ...Garland J. ScottPresident and CEOPayment of ExerciseF12.895,62372,480177,928183.6 K to 177.9 K (-3.06 %)
Feb 04 2020PTLAPORTOLA PHARMACEUT ...Garland J. ScottPresident and CEOGrantA0.0050,0000183,551133.6 K to 183.6 K (+37.44 %)
Nov 04 2019PTLAPORTOLA PHARMACEUT ...Garland J. ScottPresident and CEOPayment of ExerciseF29.8421,549643,022133,551155.1 K to 133.6 K (-13.89 %)
Feb 04 2019PTLAPORTOLA PHARMACEUT ...Garland J. ScottPresident and CEOOption ExerciseA27.10120,4003,262,840120,400
Feb 04 2019PTLAPORTOLA PHARMACEUT ...Garland J. ScottPresident and CEOGrantA0.0030,1000155,100125 K to 155.1 K (+24.08 %)
Oct 31 2018PTLAPORTOLA PHARMACEUT ...Garland J. ScottPresident and CEOOption ExerciseA19.69250,0004,922,500250,000
Oct 31 2018PTLAPORTOLA PHARMACEUT ...Garland J. ScottPresident and CEOGrantA0.00125,0000125,0000 to 125 K

Page:   1